BRITTANY RIGSBY: Open Payments
NPI 1548359185 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,320 in 71 payments from 16 companies in 2025. Trend: 2023 $1,373 · 2024 $1,709 · 2025 $1,320
Food & beverage: $1,320
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 18 | $283 |
| Incyte Corporation | 4 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $147 |
| MAYNE PHARMA COMMERCIAL LLC | 14 | $143 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| ABBVIE INC. | 3 | $84 |
| Amgen Inc. | 4 | $69 |
| Galderma Laboratories, L.P. | 4 | $65 |
| Lilly USA, LLC | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $43 |
Products named: Zoryve, ILUMYA, Winlevi, OTEZLA, SKYRIZI, EBGLYSS, NEMLUVIO, TREMFYA.
Industry payments across AL — which companies pay providers there.
